5-Chloro-2-cyclohexylamino-3-fluoropyridine

Catalog No. :
ACZGQT643
CAS No. :
1020253-24-0
Molecular Formula :
C11H14ClFN2
Molecular Weight :
228.70

IUPAC Name:5-chloro-N-cyclohexyl-3-fluoropyridin-2-amine

5-Chloro-2-cyclohexylamino-3-fluoropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$78.00Login to see priceInquiryInquiry
5g98%$136.00Login to see priceInquiryInquiry
25g98%$311.00Login to see priceInquiryInquiry
100g98%$719.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-2-cyclohexylamino-3-fluoropyridine
IUPAC Name5-chloro-N-cyclohexyl-3-fluoropyridin-2-amine
MDL No.MFCD09972201
Molecular FormulaC11H14ClFN2
Molecular Weight228.70
SMILESFC1=CC(Cl)=CN=C1NC2CCCCC2
InChI KeyNEAIMLCKTCIVPG-UHFFFAOYSA-N
Synonym5-CHLORO-2-CYCLOHEXYLAMINO-3-FLUOROPYRIDINE | 1020253-24-0 | 5-chloro-N-cyclohexyl-3-fluoropyridin-2-amine | DTXSID80674405 | MFCD09972201 | AKOS015848865 | BS-19195 | CS-0212329 | 2-Pyridinamine, 5-chloro-N-cyclohexyl-3-fluoro- | A896921
CAS No.1020253-24-0
PubChem CID46738754

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZGQT643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYRPS582 route compound structure diagram
    ACYRPS582246847-98-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZGQT643 route product structure diagram
    ACZGQT6431020253-24-0
Inquiry

2. ACZGQT643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZGQT643 route product structure diagram
    ACZGQT6431020253-24-0
Inquiry

Comments (0)